*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

yeah mick you are usually totally unbiased....

From an earlier post (might have been mine) relating to PCA3plus:

Below is a list of UK hospitals that offer the PCA3Plus test,which from what I can gather are then sent to Bostwick's Lab in London for analysis and results returned:

Spire Roding Hospital (Redbridge near Ilford in Essex)
Spire Bushey Hospital (Watford,Hertfordshire)
Spire Tunbridge Wells Hospital (Kent)
Spire Gatwick Park Hospital (Surrey)
Spire Parkway Hospital (Solihull,West Midlands)
The Wellington Hospital (St Johns Wood,London)


along with:

"Now, with the availability of this highly portable technology that requires only a small sample of blood from a finger prick, it is feasible that worried patients can have their PSA result and understand their level of prostate cancer risk during their lunch break. Mr Tim Larner, a Consultant Urologist at the Spire Gatwick Park Hospital, believes the test will significantly shorten the diagnostic pathway for prostate cancer and lead to much-needed efficiencies in the delivery of healthcare. We have come to rely heavily on the PSA test for prostate cancer screening in the UK, and it forms an important part of the specialist referral criteria used by GPs, he says. This test will be invaluable for patients who have active surveillance of their PSA levels or for patients who need regular monitoring of disease progression or success of treatment. For these patients, any delay can cause extreme anxiety and unnecessary distress.

The launch of PSAWatch follows rapidly on from the launch last year of another major advance in the prostate cancer testing the PCA3Plus test. This highly-specific urine test measures genetic markers of prostate cancer and is an extremely reliable method of detecting the presence of cancer cells in the urine. These two new tests, when taken together, could really change the outlook for men we suspect to have prostate cancer, says Larner. This simple finger-prick test enables us to rapidly identify at-risk men who warrant further investigation whilst the PCA3Plus test enables accurate identification of cancer risk following an unclear biopsy result. This means we should miss fewer early-stage patients and put fewer people through unnecessary repeated biopsies.

For more information please contact the Sales and Marketing Team - Beaulieu-Taylor Harris or Caroline Randle on 01293 778906. "

http://www.spirehealthcare.com/gatwickpark/News/NEW-LUNCHTIME-TEST-FOR-PROSTATE-CANCER-LAUNCHED-IN-THE-UK/


The map below shows the spread of Spire hospitals and at the last count there were 36.Therefore due to the basic training required to carry out a PSA test using the PSAwatch/Bioscan method,could we then extrapolate and say there are or in time there could be at least 36 Bioscans purchased just by this one company?
Not a great deal of revenue at the estimated price of 1800 each in 2007 which would equate to 64,800 but it's just an estimate of one company in the UK!
Then there is of course the purchase of the PSAwatch test strips,one for each test.

http://www.spirehealthcare.com/locate-a-hospital/

I still think PSAwatch is an added bonus for the sale of the whole MDW range and as said before,what an added bonus it could be!

PSAwatch/Bioscan (after all these years of mediwatching) is now at the key stage as in,will it be taken on-board throughout the non-FDA requiring countries,now that is the question? If it is then it doesn't really matter when FDA approvals arrive as success in EU or other countries for example Australia/New Zealand will ensure a continuation of profit status by a major margin with the eventual USA market defining MDW as the world number one in Urology diagnostics for the sector they aim for of course.


There are no other companies that offer the complete package for the Urologist that MDW can deliver in the whole of the world-fact............from my extensive research and happy,well I wouldn't be,to be proved wrong :-)


Edit-I'd better add this,Ohh and please do your own research as in these troubled times ect ect ect

This article is of interest for a few reasons but mainly that Leighton Hospital is a NHS Foundation Trust hospital and so part of the NHS.

Yes,Mr Steele couldn't give the test away initially-lol but although he had the best intentions,maybe not the right way of going about,imo.An MDW rep.would have been the best option and he does say 'some time back' and a lot has changed since then!

Good that MDW were prepared the give a few Bioscans away at a cheaper price as it was or still is early days for PSAwatch.

Page 9 in link below "Chance to catch the Silent Killer"

http://issuu.com/trinitymirrorcheshire/docs/midcheshirechronicle42?mode=embed&documentId=081015085352-46df9eec79d04dd281a114f07e7233fd&layout=grey

Below are just some 'ball park' figures and are only on the assumption that PSAwatch takes off!

Group turnover was 4,371,000 (Mediwatch Interim Results published 29 July 2008 for the six month period ended 30 April 2008) and without revenue from PSAwatch.

I'll try and put an objective/conservative view forward:

The UK by end of 2009 could see sales of the Bioscan numbering 200 (my view would be a lot more) so based on 2007 figures that would equate to 360,000 plus the test sticks,lets say 150k a year at 5 = 750,000 giving a total of 1.1 million

Now lets say that 70 countries can generate similar figures,therefore a figure of 70million is about right for MDW revenue and just for PSAwatch!

The above doesn't include the USA-lol

All depends on the success of PSAwatch at end of day...................

14 November 2008

Rugby fans invited to join heroes at dinner for The Prostate Cancer Charity
Rugby Union legend, Andy Ripley, will be among the speakers at a special dinner being hosted in aid of The Prostate Cancer Charity.

Ripley, who gained 24 caps for England, will address guests at the Capital Sporting Dinner to be held on Wednesday 26 November, speaking of his time as a player and also his personal battle with prostate cancer. The committed supporter of The Prostate Cancer Charity will be joined by fellow rugby greats, Willie John McBride and Sean Fitzpatrick, at the event at the London Marriott Hotel, who will speak about their stellar careers. Renowned comedian, Rob Woodward, will also perform.

John Neate, Chief Executive of The Prostate Cancer Charity, said: Prostate cancer is now the most common cancer diagnosed in men in the UK. 35,000 men are diagnosed with prostate cancer every year and 10,000 men die of the disease. The Capital Sporting Dinner is a rare opportunity for rugby fans to enjoy hearing from three of Rugby Unions finest players, as well as raising money for the Charity. I hope the dinner is a great success.

The event is being organised by The Capital Sporting Club and all proceeds on the night will go directly to The Prostate Cancer Charity.

Tickets cost 117.50 each and can be booked online at www.sportingclubgroup.com/capital.asp or by phone on 01373 830720.

http://www.prostate-cancer.org.uk/news/news_detail.asp?id=1162

lol....re post 1335.....nice try Mick....absolute nonsense as usual...lol

minder....are you going to pull Mick up for talking rubbish....no i thought not

why do the directors not want shares at 4p? fact.

i see Mick's ramping has reached new heights...he has a 70p target on advfn.....funny that if the directors could see that they would surely have taken their options at 4p......but they didnt...so they must think it is overvalued at that level...

70p.......do you wear long shoes and have a red nose?...lol

New Findings Offer Fresh Hope To Men With Prostate Cancer That Has Returned After Attempted Cure
Main Category: Prostate / Prostate Cancer
Also Included In: Cancer / Oncology | Urology / Nephrology
Article Date: 16 Nov 2008

The link between the PSA (prostate-specific antigen) blood test and the detection of prostate cancer is well-established. In new findings released publicly for the first time today, Australian and New Zealand researchers have demonstrated how two serial measures of PSA can be used to accurately predict a patient's prognosis when prostate cancer returns after attempted cure.

Survival can vary enormously among patients whose prostate cancer returns after curative treatments (such as surgery or radiotherapy). Some men can live for many years without the need for treatment however others will have very limited survival in spite of immediate intervention. Up to now, doctors have not been able to predict survival in these men and therefore have not been able to identify those who would benefit from participating in trials of new therapies. Nor have they known which men are able to avoid treatment for many years and therefore not risk the side effects that these treatments commonly cause.

Radiation oncologist and TROG (Trans-Tasman Radiation Oncology Group) researcher at Calvary Mater Newcastle, Professor Jim Denham and colleagues from Australia and New Zealand obtained the results by examining data from one of the world's largest prostate cancer clinical trials - TROG 96.01.

"PSA has been commonly used in clinical management of the disease but up until now, no one has been able to forecast accurately what will happen when cancer returns after curative treatment. Two factors - the time for PSA to rise after curative treatment and the speed at which the PSA is rising - are powerful prognostic tools for specialists and can now be used to plan future treatments on a sounds basis," Professor Denham said.

The findings were announced on Thursday at the 2008 Prostate Cancer Meeting - 'Defining our Future'. The summit brought together national and international experts to define new pathways for research into prostate cancer.

The trial was supported by the NHMRC, AstraZeneca and Schering-Plough.

TRoG Cancer Research
www.trog.com.au

http://www.medilexicon.com/medicalnews.php?newsid=129549

Some interesting views over the road,I was going to buy some more MDW shares but will wait and see what happens me thinks!


"banjomick - 16 Nov'08 - 23:50 - 19108 of 19113 edit


What is your view regarding MDW?

6500slider - 17 Nov'08 - 00:06 - 19109 of 19113


banjo,

You don't want to know mate, I think I was actually one of the 'negative' posters that pissed you off in the first place! Anyway, they have held up reasonably well it has to be said but I really don't trust the management as there have been far too many "damaging" RNS's and this rumoured review absolutely beggars belief... too funny for words really! They were apparently reading this thread and only got the jist of how shite their RNS's were after the last one - give me a break! They must have missed the collapsing share price eh? I think they plan a cheap take out and it's all been by design. AIMO.

You did ask ;o)."


"6500slider - 17 Nov'08 - 06:58 - 19111 of 19113


banjo,

No worries, each to their own. Maybe the 'funding' window of opportunity has passed them by and now they need to roll up their sleeves and make this work... they have no choice. AIMO."

"TimTom2 - 17 Nov'08 - 21:55 - 19112 of 19113


I've seen a couple of small caps recently go tits-up and one tried to get clever and close the UK parent whilst the US management bought-out the company leaving the uk high and dry - a long story. Anyway, they ballsed-up and the management buy-out funding was pulled at the very last minute. So last minute the US management were sitting in a meeting room waiting for the Private Equity folk to show and they didn't.

Summary: MDW have no choice but to roll-up their sleeves and make a go of this as getting clever now is asking for trouble."

Three news items from the Prostate Charity today:

http://www.prostate-cancer.org.uk/news/news.asp

I just know my good mate is there,waiting,ready to pounce but MDW are holding up rather well.

Of interest:


Calls for survival rates overhaul

Friday, November 21, 2008, 01:25


"Up to 11,000 lives a year could be saved if cancer survival rates in Great Britain matched the best in Europe, according to new research.

England, Scotland and Wales lag behind most other European countries when it comes to survival rates for the disease.

A major Eurocare study published last year showed that five-year survival rates for lung, breast, prostate and colorectal cancer were lower in the whole of the UK than in other countries apart from eastern Europe."


"Lead researcher, Professor Michel Coleman, said: "Our research suggests that if we could make further improvements in diagnosis we could save thousands more lives each year."

The research is being presented at the launch of the National Awareness and Early Diagnosis Initiative (NAEDI) to cut the number of people needlessly dying from cancer in Britain."

http://www.thisisbath.co.uk/nationalnews/Calls-survival-rates-overhaul/article-491298-detail/article.html

"Trust News East Kent Hospitals University NHS Trust
31 October 2008

New scanner to speed up diagnoses

Thank you to the Prostate Cancer Association (PSA) who have been working tirelessly on our behalf to raise enough money to provide specialist scanners for our Oncology and Urology departments.

This week a portable multi scanner complete with accessories and test kits enabling a ten minute diagnostic blood test to detect Prostate cancer was presented to Urology Consultants Mr Shrotri, Mr Choi and Mr Murray.

The PSA has already purchased similar portable scanners for Kent & Canterbury Oncology, QEQM,and Royal Victoria, Folkestone, allowing us to test patients quickly and effectively, even carrying out home visits as necessary."


If you want to view the PDF then c&p and google wording below and open file:



'31 October 2008 New scanner to speed up diagnoses'

If anyone has opened the PDF then the scanner shown in the picture is the Multiscan and from the wording it's not difficult to know they also have the Bioscan and PSAwatch sticks.

http://www.mediwatch.com/Multiscan.php

The other hospitals mentioned must have the Portascan+ and may have the Bioscan and PSAwatch sticks too.

http://www.mediwatch.com/Portascan.php

zzzzzzzzzzzzzzzzzzzzzzzzz.......................

An interesting article:

The world is in the grip of an economic downturn. So how is the healthcare sector faring?

"The double-digit growth forecast at the start of the year appears, at best, optimistic. In fact, such is the volatility of the markets at present that growth of any kind seems to be the exception rather than the rule. Despite this, the outlook for the medtech sector appears much more encouraging than that for many other global business sectors.

A recent report by management consultancy McKinsey states that the European medical technology market is growing at a rate of 56% each year a model of consistency in an otherwise turbulent economic climate. Espicom Business Intelligence, a leading provider of independent market information, is even more bullish, predicting that the 11 main medical device markets in Western Europe will grow by over 40% within the next five years. Its report The Outlook for Medical Devices in Western Europe forecasts that the medical device market in these 11 key regions will reach a collective value of US$82.4 billion by 2013 which is US$24.1 billion greater than its current position."

http://www.ontargetmag.com/article.aspx?issueID=126&articleID=925

Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis


Article Date: 24 Nov 2008 - 3:00 PST


During the follow-up period, 2,546 men were diagnosed with CaP; 989 (38.8%) were overweight and 87 (3.4%) were obese. More obese men were past smokers and more likely to have extraprostatic or metastatic CaP or high Gleason grade tumors at diagnosis. BMI was not related to PSA concentration, which is important as other studies have suggested the increased circulating plasma volumes in obese men decrease their measurable PSA levels. Higher baseline C-peptide levels correlated with older age. During 24 years of follow-up, 281 of 2,546 men (11%) died from CaP and 485 (19%) died from other causes. A higher baseline BMI was significantly associated with a higher risk of PCSM, independent of age at diagnosis and baseline smoking status, compared with a healthy BMI (hazard ratio 1.47 for overweight men and 2.66 for obese men). This remained statistically significant after controlling for clinical stage and Gleason grade. Further controlling for PSA strengthened the association of being overweight (HR1.8), but attenuated the association for obesity (HR 1.6). Interestingly, among men diagnosed during the pre-PSA era, 33.7% died from CaP compared to 6.6% in the PSA screening era.

http://www.medicalnewstoday.com/articles/130468.php

Hmmmmm,will have to read this again later as I'm not sure if it's +/- regarding the PSA test, lol

Inverse Association Between Histologic Inflammation In Needle Biopsy Specimens And Prostate Cancer In Men With Serum PSA Of 10-50 Ng/ML

Thus, the sensitivity was 87.2%, specificity 63.2%, positive predictive value 78.1%, and negative predictive value 76.6%.

http://www.medicalnewstoday.com/articles/130465.php

10/11/2008

THE NEW LUNCH HOUR PSA TEST OFFERS IMMEDIATE RESPONSE TO CANCER CONCERNS

The Birmingham Prostate Clinic is the first in the West Midlands to offer the 10-minute PSA test in order to offer men a more rapid response to whether they are at risk from cancer.

Many thousands of men have PSA tests every year, as the standard way of screening for risk of prostate cancer, the most common form of male cancer.

A raised PSA result is not a diagnosis of prostate cancer but an indication that the patient may be at risk and require further investigations.

Patients typically wait days or weeks for their PSA results, while their test is sent to a laboratory and a second appointment to discuss the results with the doctor is made.

However, The Birmingham Prostate Clinic is the first in the West Midlands to introduce new technology which produces an accurate PSA result in just 10 minutes.

Called PSAwatch, it is a hand-held device into which blood samples can be inserted. The device has a screen which displays the results 10 minutes later.

Analysis has shown that PSA Watch is as accurate as sending blood samples to a laboratory.

The big benefit of this new development is it enables the patient to discuss his results with a consultant immediately, explains Consultant Urologist Alan Doherty of The Birmingham Prostate Clinic.

By accessing the bladder through five keyhole-sized holes in the abdomen, the damage to tissue and nerves is minimised and blood loss is much reduced.

Instead of sending patients home, often feeling very anxious about their results before returning to clinic days or weeks later, we can offer them an almost instant response.

That may be to reassure them that they are not at risk of prostate cancer, or we may need to arrange for further tests to take place. In either scenario, we are able to eradicate that period of anxiously waiting.

PSA stands for Prostate Specific Antigen, a protein made by the prostate which naturally leaks into the bloodstream when the prostate is damaged.

A simple blood test can be taken to measure levels of PSA and a high reading indicates prostate cancer may be present.

However, a raised PSA can also be caused by a non life-threatening condition called an enlarged Benign Prostatic Hyperplasia (BPH).

Risk of prostate cancer is assessed by taking a number of different factors into account as well as PSA level, says Mr Doherty.

We consider the patients age, family history, previous PSA tests and carry out an examination of his prostate.

PSA results are notoriously difficult to interpret and it is important for patients to receive their PSA results during a consultation with a doctor, who is able to explain what the results mean and discuss what steps should be taken.

Combined with the new PCA3 test, we now have some very powerful new diagnostic tools for prostate cancer.

Both the PCA3 test and PSAwatch have been produced by Mediwatch, based in Rugby, Warwickshire.


http://www.birminghamprostateclinic.co.uk/news_10_11_08.php

Ahhhhhhhh that's good as the end of the above ie:

"Both the PCA3 test and PSAwatch have been produced by Mediwatch, based in Rugby, Warwickshire"

Confirms that the PCA3 mentioned in post below is indeed the PCA3Plus test which is the MDW test.


"banjomick - 10 Oct 2008 21:30 - 1114 of 1350

This part is pure speculation on my part that the Birmingham Prostate Clinic is using MDW products ie PSAwatch and PCA3plus

Firstly regarding the PSA test and the announcement below which basically takes on board the new guidelines put forward by the AUA last year,which is very good news in my opinion.There is nothing to suggest that PSAwatch is being used at this clinic but there is nothing to say that it won't be used in the future or the patient given a choice of wait a few days or a few minutes for results.

19/09/2007 MEN URGED TO KNOW THEIR PSA FINGERPRINT TO GUARD AGAINST THE RISKS OF PROSTATE CANCER


Secondly PCA3plus and the announcement below.What strikes me within this announcement is the lack of the PCA3 manufacturer being mentioned eg PROGENSA PCA3,PCA3 ProfileR or indeed PCA3Plus which is unusual.

24/09/2007 DNA TECHNOLOGY BROUGHT INTO THE FIGHT AGAINST PROSTATE CANCER "